-
Mashup Score: 0The Next President Should End NASA’s Space Launch System Rocket - 1 hour(s) ago
Rather than building an obsolescent, obscenely-over-budget jumbo rocket, NASA should turn to building truly innovative space technologies and plan a realistic lunar landing program
Source: www.scientificamerican.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 0Hydroxychloroquine and risk of osteoporosis in patients with rheumatoid arthritis: A population‐based retrospective study of 6408 patients - 1 hour(s) ago
Aim Patients with rheumatoid arthritis (RA) are at a higher risk of osteoporotic fractures. Studies have shown that patients with Sjogren’s syndrome (SS) and systemic lupus erythematosus (SLE) exper…
Source: onlinelibrary.wiley.comCategories: General Medicine News, RheumatologyTweet-
Retrospective Taiwan's Health claims: studied 6408 RA pts, half HCQ users vs non-users. No higher risk of osteoporosis in HCQ users vs non-users (aHR=0.99; 95% CI: 0.82–1.196). Why study this? HCQ may suppress both bone formation/resorption https://t.co/xShLXMElnH https://t.co/lkvihaYuAd
-
-
Mashup Score: 0Fear of progression, imagery, interpretation bias, and... : PAIN - 1 hour(s) ago
re not well understood in endometriosis. The aim of this study was to investigate the relevance of fear of progression, imagery, and interpretation bias in endometriosis, and their contribution to pain interference. A total of 221 participants (mean age = 38 years, SD = 7.8) with endometriosis were recruited from Endometriosis Australia. This cross-sectional study included relevant demographics and endometriosis characteristics; questionnaires to measure fear of progression, imagery, interpretation bias, and pain; and the word association task to measure interpretation bias. Participants reported high scores on the Fear of Progression Questionnaire (M = 38/60), higher than that has been found in cancer. Controlling for age and pain intensity, we found that imagery, interpretation bias, and their interaction were associated with increased fear of progression and that fear of progression was associated with greater pain-related interference. In exploratory analysis, we also found that th
Source: journals.lww.comCategories: General Medicine News, RheumatologyTweet-
Check out articles like “Fear of progression, imagery, interpretation bias, and their relationship with endometriosis pain” by @JemmaLTodd et al. in #PAIN https://t.co/OiVf08lp8z #painawarenessmonth #painisreal #endo https://t.co/VQ6fDouRkk
-
-
Mashup Score: 05 Ways Software License Management Benefits Your Business - 1 hour(s) ago
Software powers enterprise operations. It enables data flows, automates processes, provides an exceptional user experience, and surfaces insights for team
Source: www.device42.comCategories: General Medicine News, General HCPsTweet-
Maximize your software investments! Learn how effective license management can reduce costs and improve compliance with @Device42: https://t.co/6eEewsnhjq - #SoftwareManagement #ITCompliance
-
-
Mashup Score: 0The EvoPAR-Prostate 01 Trial: Novel PARP Inhibitor Saruparib in mHSPC - Neeraj Agarwal - 1 hour(s) ago
Zach Klaassen discusses the EvoPAR-Prostate 01 trial with Neeraj Agarwal. The trial examines a new PARP inhibitor combined with ARPI in metastatic hormone-sensitive prostate cancer, both in biomarker-positive and -negative populations. Dr. Agarwal explains the rationale based on preclinical data and previous trials like PROpel and TALAPRO-2, showing efficacy in HRR mutation-positive patients and…
Source: www.urotoday.comCategories: General Medicine News, UrologyTweet-
The EvoPAR-Prostate 01 Trial: Novel PARP inhibitor saruparib in #mHSPC. @neerajaiims @huntsmancancer and @zklaassen_md @GACancerCenter discuss this new PARP inhibitor combined with ARPI in both biomarker-positive and --negative populations. #WatchNow > https://t.co/5mne7KazB9 https://t.co/xKdfbQZwJI
-
-
Mashup Score: 0ESMO Annual Congress - 1 hour(s) ago
Urology Times is the leading resource for urologists & allied health professionals offering clinical analysis, policy perspectives, & practical advice.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet-
That’s a wrap on #ESMO24! You can keep up with our ongoing coverage of the meeting here: https://t.co/69eMaO6g4p https://t.co/xm8gQT35CJ
-
-
Mashup Score: 0The Pivotal Role of Germline BRCA2 Pathogenic Variants in “Apparently Sporadic” Pancreatic Cancer - 1 hour(s) ago
Abstract. In 1996, Goggins and colleagues demonstrated the importance of germline BRCA2 pathogenic variants in the development of apparently sporadic pancreatic ductal adenocarcinoma (PDAC). Previously, the group identified homozygous deletion of the 13q region in PDACs, enabling the identification of the BRCA2 gene. This 1996 article first revealed loss of BRCA2, both germline and somatic, as a key driver of PDAC at a time when there was still doubt if PDAC even had an inherited component. Contrary to the prevailing wisdom, not all individuals with inherited pathogenic BRCA2 variants had a family history of cancer. The innovative bedside-to-bench nature of this work revealed that individuals with these variants would be missed if genetic testing was limited only to those meeting the family history criteria. Therefore, Goggins and colleagues advocated that universal genetic testing may be indicated for pancreatic cancer at a time when genetic testing was in its infancy. Twenty-three ye
Source: aacrjournals.orgCategories: General Medicine News, Oncologists1Tweet-
If you’re attending Plenary Session 7: Tumor Cell Biology at #AACRpan24, don’t miss this Landmark commentary by @Jon_BrodyPhD and @alisonpklein—The Pivotal Role of Germline #BRCA2 Pathogenic Variants in “Apparently Sporadic” #PancreaticCancer. https://t.co/iJ11uhKWyg https://t.co/TI0fSbMoO5
-
-
Mashup Score: 0RIST Prolongs PFS, OS in MYCN-Amplified Neuroblastoma - 1 hour(s) ago
RIST improved outcomes over irinotecan-temozolomide in patients with MYCN-amplified, relapsed or refractory neuroblastoma in a phase 2 trial.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Oncologists1Tweet-
The combination of RIST can improve outcomes when compared to irinotecan-temozolomide only in patients with MYCN-amplified, relapsed or refractory #neuroblastoma. Published in @TheLancetOncol. https://t.co/oXF1VwciQ1
-
-
Mashup Score: 1Visit the Spot Her website - 1 hour(s) ago
Learn about the signs and symptoms of endometrial cancer, hear stories from real patients, and access educational materials.
Source: www.spotherforec.comCategories: General Medicine News, PayerTweet-
The #SpotHerForEC team had an incredible time talking to everyone at the Dallas Ultimate Women’s Expo! If you missed it, you can learn more about spotting the signs of #endometrialcancer and find gynecologic cancer resources on the Spot Her website: https://t.co/ceqyKzWHDv https://t.co/bMNWWodD0j
-
-
Mashup Score: 0Hackensack Meridian Health inks partnership with K Health to roll out virtual primary care service - 1 hour(s) ago
New Jersey-based Hackensack Meridian Health is teaming up with K Health to launch a new 24/7 virtual primary care service to provide easier access to the health system’s clinicians. | New Jersey-based Hackensack Meridian Health is teaming up with K Health to launch a new 24/7 virtual service to provide easier access to the health system’s clinicians for primary care.
Source: www.fiercehealthcare.comCategories: General Medicine News, General HCPsTweet-
Health systems are investing more in hybrid care services to integrate virtual and in-person care. @HMHNewJersey inked a partnership with @khealth to launch an app, HMH 24/7, for primary care https://t.co/27bOqkCoyX
-
Rather than building an obsolescent, obscenely-over-budget jumbo rocket, NASA should turn to building truly innovative space technologies and plan a realistic lunar landing program | Opinion https://t.co/NgOZJ8d1el